BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38199607)

  • 1. Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models.
    Hu J; Lazar AJ; Ingram D; Wang WL; Zhang W; Jia Z; Ragoonanan D; Wang J; Xia X; Mahadeo K; Gorlick R; Li S
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38199607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors.
    Hu J; Yang Q; Zhang W; Du H; Chen Y; Zhao Q; Dao L; Xia X; Natalie Wall F; Zhang Z; Mahadeo K; Gorlick R; Kopetz S; Dotti G; Li S
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35027427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma.
    Yang Q; Hu J; Jia Z; Wang Q; Wang J; Dao LH; Zhang W; Zhang S; Xia X; Gorlick R; Li S
    Clin Cancer Res; 2022 Sep; 28(17):3862-3873. PubMed ID: 35727602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting integrin α5 in fibroblasts potentiates colorectal cancer response to PD-L1 blockade by affecting extracellular-matrix deposition.
    Lu L; Gao Y; Huang D; Liu H; Yin D; Li M; Zheng J; Wang S; Wu W; Zhao L; Bi D; Zhang Y; Song F; Xie R; Wang J; Qin H; Wei Q
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
    Ishimoto T; Miyake K; Nandi T; Yashiro M; Onishi N; Huang KK; Lin SJ; Kalpana R; Tay ST; Suzuki Y; Cho BC; Kuroda D; Arima K; Izumi D; Iwatsuki M; Baba Y; Oki E; Watanabe M; Saya H; Hirakawa K; Baba H; Tan P
    Gastroenterology; 2017 Jul; 153(1):191-204.e16. PubMed ID: 28390866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapy.
    Das S; Valton J; Duchateau P; Poirot L
    Front Immunol; 2023; 14():1172681. PubMed ID: 37251405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression.
    Du X; Xu Q; Pan D; Xu D; Niu B; Hong W; Zhang R; Li X; Chen S
    Cell Death Dis; 2019 Nov; 10(12):873. PubMed ID: 31740661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Chemoimmunotherapy Augmentation via Sequential Nanocomposite Hydrogel-Mediated Reprogramming of Cancer-Associated Fibroblasts in Osteosarcoma.
    Wang H; Chen Y; Wei R; Zhang J; Zhu J; Wang W; Wang Z; Wupur Z; Li Y; Meng H
    Adv Mater; 2024 Apr; 36(15):e2309591. PubMed ID: 38113900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IR-780 Dye-based Targeting of Cancer-associated Fibroblasts Improves Cancer Immunotherapy by Increasing Intra-tumoral T Lymphocytes Infiltration.
    Yang W; Chen Z; Qu L; Zhang C; Chen H; Zheng J; Chen W; Tan X; Shi C
    Curr Cancer Drug Targets; 2024 Jan; ():. PubMed ID: 38310462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
    Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
    Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer.
    Strating E; Verhagen MP; Wensink E; Dünnebach E; Wijler L; Aranguren I; De la Cruz AS; Peters NA; Hageman JH; van der Net MMC; van Schelven S; Laoukili J; Fodde R; Roodhart J; Nierkens S; Snippert H; Gloerich M; Rinkes IB; Elias SG; Kranenburg O
    Front Immunol; 2023; 14():1053920. PubMed ID: 37261365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.
    Moatassim-Billah S; Duluc C; Samain R; Jean C; Perraud A; Decaup E; Cassant-Sourdy S; Bakri Y; Selves J; Schmid H; Martineau Y; Mathonnet M; Pyronnet S; Bousquet C
    Oncotarget; 2016 Jul; 7(27):41584-41598. PubMed ID: 27177087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies.
    Mhaidly R; Mechta-Grigoriou F
    Semin Immunol; 2020 Apr; 48():101417. PubMed ID: 33077325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
    Paauwe M; Schoonderwoerd MJA; Helderman RFCP; Harryvan TJ; Groenewoud A; van Pelt GW; Bor R; Hemmer DM; Versteeg HH; Snaar-Jagalska BE; Theuer CP; Hardwick JCH; Sier CFM; Ten Dijke P; Hawinkels LJAC
    Clin Cancer Res; 2018 Dec; 24(24):6331-6344. PubMed ID: 29945992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell-derived cancer-associated fibroblasts are novel contributors to the pro-tumorigenic microenvironment.
    McDonald LT; Russell DL; Kelly RR; Xiong Y; Motamarry A; Patel RK; Jones JA; Watson PM; Turner DP; Watson DK; Soloff AC; Findlay VJ; LaRue AC
    Neoplasia; 2015 May; 17(5):434-48. PubMed ID: 26025666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
    Yoshida GJ
    J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblasts-derived HAPLN1 promotes tumour invasion through extracellular matrix remodeling in gastric cancer.
    Zhang T; Li X; He Y; Wang Y; Shen J; Wang S; You Q; Zhai J; Shen L
    Gastric Cancer; 2022 Mar; 25(2):346-359. PubMed ID: 34724589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcoma.
    Liu Y; Han X; Han Y; Bi J; Wu Y; Xiang D; Zhang Y; Bi W; Xu M; Li J
    Gene; 2024 May; 907():148286. PubMed ID: 38367852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.